Following a recent paper on the role of seawater in the treatment of upper respiratory infections published in the scientific journal Marine Drugs, we proudly announce a new scientific publication that confirms the efficacy and reliability of Aqua Maris Strong in a group of users with specific needs – school-age children.
The paper entitled “Multicenter, randomized, open-label, comparative study of the effectiveness of nasal spray Aqua Maris Extra Strong as a symptomatic therapy in the technology of delayed antibiotic prescription in the treatment of acute rhinosinusitis in children aged 6-11 years” was published in the reputable academic journal Elsevier: American Journal of Otolaryngology.
The paper confirms that using Aqua Maris Strong for treating rhinosinusitis symptoms in school-age children reduces the severity and duration of symptoms, as well as the risk of the otherwise frequent recurrences of secondary bacterial infections. The full text of the article is available here.